Scrutinizing supplements: creatine, fish oil, vitamin D, and more (AMA 69 Sneak Peek)
Key Moments
Peter Attia framework for supplements: analyze risk/reward, mechanism, biomarkers, goals.
Key Insights
Supplements are not regulated like pharmaceuticals, requiring careful consumer evaluation.
A structured framework is essential for assessing supplement efficacy and relevance.
Creatine offers modest benefits for muscle performance and potentially cognitive function with low risk.
Fish oil quality is crucial; its benefits depend on specific EPA/DHA levels and individual needs.
Vitamin D supplementation is often necessary due to widespread deficiency, with dosage based on blood levels.
B vitamins are typically obtained adequately through diet or oral supplements, with IV less common for general use.
THE SUPPLEMENT LANDSCAPE AND REGULATORY CHALLENGES
Supplements operate in a less regulated environment compared to pharmaceuticals. While often perceived as inherently 'natural' and safe, their production and claims are not subject to the same rigorous oversight as drugs. This lack of stringent regulation means consumers must be particularly vigilant about quality and efficacy. Peter Attia emphasizes that the distinction between 'natural' supplements and pharmaceuticals can be misleading, urging a consistent analytical approach to all ingested molecules.
A FRAMEWORK FOR SUPPLEMENT EVALUATION
To navigate the complex world of supplements, Attia proposes a framework centered on key questions. These include assessing whether the supplement aims to correct a deficiency or achieve supra-physiological levels, its potential impact on lifespan and healthspan (physical, cognitive, emotional), the existence of trackable biomarkers, understanding its mechanism of action, and a thorough risk-reward analysis including side effects and data confidence.
CREATINE: PERFORMANCE AND COGNITIVE BENEFITS
Creatine supplementation primarily targets supra-physiological levels for enhanced athletic performance, particularly in activities requiring short bursts of intense energy due to its role in replenishing ATP. While direct lifespan benefits are unproven, it can contribute to healthspan by maximizing exercise benefits and potentially mitigating cognitive decline. Safety data is robust, classifying it as low-risk, though individuals with impaired kidney function should consult a doctor due to potential impacts on creatinine levels.
FISH OIL: QUALITY AND TARGETED NUTRITION
The efficacy of fish oil hinges significantly on the quality of the supplement, with a recommendation for smaller fish to minimize rancidity. While widely taken, its benefits are tied to specific EPA and DHA content and individual needs. Attia stresses the importance of evaluating fish oil within the broader framework, considering its potential impact on healthspan and the need for personalized dosage based on blood work rather than general recommendations.
VITAMIN D: ADDRESSING A COMMON DEFICIENCY
Vitamin D deficiency is prevalent, making supplementation often necessary to achieve optimal levels rather than purely correcting a deficiency. Its role in overall healthspan is significant, impacting numerous bodily functions. Attia highlights that dosage should be guided by blood level testing rather than arbitrary recommendations, ensuring individuals fall within the therapeutic window without risking toxicity. The convenience of oral supplementation generally outweighs other forms for most people.
B VITAMINS AND ASHWAGANDHA: SPECIFIC CONSIDERATIONS
For B vitamins, general oral supplementation is often sufficient to maintain adequate levels, smoothing out dosage compared to injections. While specific deficiencies might warrant targeted intervention, most individuals obtain adequate B vitamins through diet or standard supplements. Ashwagandha, an adaptogen, is historically used for stress and sleep, but its application requires assessment through the established framework, considering its specific intended benefits and the available evidence.
RISK-REWARD ANALYSIS AND QUALITY CONTROL
A critical component of the supplement evaluation framework is the balance of risk versus reward. This involves considering potential side effects, the magnitude of the observed effect, the confidence in the scientific data supporting its use, and crucially, the quality of the supplement itself. Attia cautions that the supplement industry has a significantly higher prevalence of quality control issues and potential for 'nefarious behavior' compared to the pharmaceutical industry.
BIOMARKERS AND MECHANISMS OF ACTION
The presence of a reliable biomarker to track supplement impact is a key question. For some supplements like creatine, direct biomarkers are not readily available outside a lab, meaning adherence to a protocol is paramount. Understanding the mechanism of action is also vital. For creatine, this involves its role in ATP regeneration for muscle power. For other supplements, a clear understanding of how they interact with biological pathways helps validate their proposed benefits.
INDIVIDUALIZED APPROACHES AND SPECIAL POPULATIONS
The discussion touches upon specific populations, noting that women might experience disproportionate benefits from creatine due to lower baseline muscle mass and potentially lower dietary intake. Pregnancy is highlighted as a period where only strictly necessary interventions should be used, with caution advised for supplement use due to limited human data. The general principle is that supplement strategies should be tailored to individual physiology and circumstances.
Mentioned in This Episode
●Supplements
●Organizations
●Concepts
●People Referenced
Supplement Evaluation Checklist
Practical takeaways from this episode
Do This
Avoid This
Common Questions
Use a framework of six key questions: assess if it's for deficiency or supranormal levels, lifespan/healthspan goals, biomarker tracking, mechanism of action, and risk/reward balance. Consider the quality of the supplement as well.
Topics
Mentioned in this video
Mentioned as an example of a supplement that can act similarly to a pharmaceutical (pravastatin) for lowering ApoB, highlighting the overlap between supplements and drugs.
Author of a previous podcast episode mentioned regarding the quality concerns of drugs, especially generics, which is extrapolated to the supplement industry.
Typically associated with B12 injections rather than oral supplements; oral supplementation provides a more smoothed out dose. Discussed as part of the case studies.
A statin drug mentioned as an example of a pharmaceutical with a similar effect to red yeast rice, used for lowering ApoB.
A molecule that acts as a phosphate donor, crucial for regenerating ATP from ADP. It is the primary energy source for short, all-out bursts of activity and is directly boosted by creatine supplementation.
More from Peter Attia MD
View all 104 summaries
135 min381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
9 minIs Industrial Processing the Real Problem With Seed Oils? | Layne Norton, Ph.D.
13 minCooking with Lard vs Seed Oils | Layne Norton, Ph.D.
146 min380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free